catechin and Lesion of Sciatic Nerve

catechin has been researched along with Lesion of Sciatic Nerve in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benov, L; Khan, KM; Renno, WM	1
Al-Banaw, A; Al-Maghrebi, M; Renno, WM	1

Other Studies

2 other study(ies) available for catechin and Lesion of Sciatic Nerve

Article	Year
Possible role of antioxidative capacity of (-)-epigallocatechin-3-gallate treatment in morphological and neurobehavioral recovery after sciatic nerve crush injury. Journal of neurosurgery. Spine, 2017, Volume: 27, Issue:5 Topics: Animals; Antioxidants; Axons; Catechin; Crush Injuries; Disease Models, Animal; Hyperalgesia; Male; Motor Activity; Nerve Regeneration; Neuroprotective Agents; Oxidative Stress; Peripheral Nerve Injuries; Random Allocation; Rats, Wistar; Recovery of Function; RNA, Messenger; Sciatic Nerve; Sciatic Neuropathy; Spinal Cord	2017
(-)-Epigallocatechin-3-gallate (EGCG) attenuates functional deficits and morphological alterations by diminishing apoptotic gene overexpression in skeletal muscles after sciatic nerve crush injury. Naunyn-Schmiedeberg's archives of pharmacology, 2012, Volume: 385, Issue:8 Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Behavior, Animal; Catechin; Desmin; Foot; Hot Temperature; Hyperalgesia; Immunohistochemistry; Male; Muscle, Skeletal; Nerve Crush; Neuroprotective Agents; Pain Measurement; Posture; Rats; Rats, Wistar; Reaction Time; Real-Time Polymerase Chain Reaction; Recovery of Function; RNA; Sciatic Neuropathy; Signal Transduction; Toes	2012

Article

Year

Possible role of antioxidative capacity of (-)-epigallocatechin-3-gallate treatment in morphological and neurobehavioral recovery after sciatic nerve crush injury.

Journal of neurosurgery. Spine, 2017, Volume: 27, Issue:5

Topics: Animals; Antioxidants; Axons; Catechin; Crush Injuries; Disease Models, Animal; Hyperalgesia; Male; Motor Activity; Nerve Regeneration; Neuroprotective Agents; Oxidative Stress; Peripheral Nerve Injuries; Random Allocation; Rats, Wistar; Recovery of Function; RNA, Messenger; Sciatic Nerve; Sciatic Neuropathy; Spinal Cord

2017

(-)-Epigallocatechin-3-gallate (EGCG) attenuates functional deficits and morphological alterations by diminishing apoptotic gene overexpression in skeletal muscles after sciatic nerve crush injury.

Naunyn-Schmiedeberg's archives of pharmacology, 2012, Volume: 385, Issue:8

Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Behavior, Animal; Catechin; Desmin; Foot; Hot Temperature; Hyperalgesia; Immunohistochemistry; Male; Muscle, Skeletal; Nerve Crush; Neuroprotective Agents; Pain Measurement; Posture; Rats; Rats, Wistar; Reaction Time; Real-Time Polymerase Chain Reaction; Recovery of Function; RNA; Sciatic Neuropathy; Signal Transduction; Toes

2012